Real-time enrollment status for this diabetic macular edema (dme) clinical trial
Current Status
Recruiting
Checked: October 9, 2026 at 8:55 PM UTC
| NCT Number | NCT07867080 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema (DME) |
| Phase | PHASE3 |
| Target Enrollment | 514 participants |
| Active Locations | 49 sites in the US |
| Sponsor | 4D Molecular Therapeutics |
| Last Updated on CT.gov | October 9, 2026 (20 hours ago) |
As of October 9, 2026: Clinical trial NCT07867080 is currently recruiting participants. This phase3 study for diabetic macular edema (dme) is actively seeking new participants at 49 locations across the United States. The study is sponsored by 4D Molecular Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07867080 is actively recruiting participants as of October 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 49 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07867080 was last updated 20 hours ago (October 9, 2026). HelloStudys verifies this status automatically.